Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BridgeBio Pharma, Inc. BBIO

Full chart Compare
Set alert

Price alert · BBIO

All alert types
74.03 USD -0.97 (-1.29%)

At closeNov 3, 2026, 7:30 PM EST

74.03 0.00 0.00%

After hours · Nov 3, 7:30 PM ET

73.95 Day range 76.79
60.22 52-week range 93.42
YTD
-3.22%
1 year
+19.44%

Financial health

Altman Z-Score

-0.09 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -20.2×
FY 2017: -83.5×FY 2018: -19.4×FY 2019: -14.1×FY 2020: -17.3×FY 2021: -4.3×FY 2022: -2.3×FY 2023: -10.2×FY 2024: -9.5×FY 2025: -20.2×
FY 2017 5y median -9.5× FY 2025
P/S 30.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 90.8×FY 2020: 1017×FY 2021: 34.5×FY 2022: 14.5×FY 2023: 706×FY 2024: 23.0×FY 2025: 30.0×
FY 2017 5y median 30.0× FY 2025
P/B -7.3×
FY 2017: -43.8×FY 2018: -15.5×FY 2019: 9.0×FY 2020: 145×FY 2021: -2.8×FY 2022: -0.9×FY 2023: -4.9×FY 2024: -3.5×FY 2025: -7.3×
FY 2017 5y median -3.5× FY 2025
P/FCF -33.8×
FY 2017: -62.1×FY 2018: -16.4×FY 2019: -14.2×FY 2020: -20.6×FY 2021: -4.4×FY 2022: -2.6×FY 2023: -12.4×FY 2024: -9.8×FY 2025: -33.8×
FY 2017 5y median -9.8× FY 2025
EV/EBITDA -25.5×
FY 2017: -59.6×FY 2018: -11.8×FY 2019: -12.2×FY 2020: -18.3×FY 2021: -7.0×FY 2022: -6.2×FY 2023: -14.0×FY 2024: -14.1×FY 2025: -25.5×
FY 2017 5y median -14.0× FY 2025
EV/Sales 34.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 84.1×FY 2020: 1034×FY 2021: 53.7×FY 2022: 31.8×FY 2023: 853×FY 2024: 27.7×FY 2025: 34.3×
FY 2017 5y median 34.3× FY 2025
FCF Yield -3.0%
FY 2017: -1.6%FY 2018: -6.1%FY 2019: -7.0%FY 2020: -4.9%FY 2021: -22.7%FY 2022: -37.9%FY 2023: -8.0%FY 2024: -10.2%FY 2025: -3.0%
FY 2017 5y median -10.2% FY 2025

Profitability

Gross Margin 94.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 93.8%FY 2020: 100.0%FY 2021: 95.5%FY 2022: 95.6%FY 2023: 73.7%FY 2024: 98.3%FY 2025: 94.4%
FY 2017 5y median 95.5% FY 2025
Operating Margin -113.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -656.4%FY 2020: -5752.0%FY 2021: -827.1%FY 2022: -659.6%FY 2023: -6528.8%FY 2024: -267.2%FY 2025: -113.3%
FY 2017 5y median -659.6% FY 2025
Net Margin -145.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -642.1%FY 2020: -5439.7%FY 2021: -806.9%FY 2022: -619.7%FY 2023: -6913.9%FY 2024: -241.4%FY 2025: -145.3%
FY 2017 5y median -619.7% FY 2025
ROE 35.1%
FY 2017: 52.7%FY 2018: 79.7%FY 2019: -63.8%FY 2020: -774.9%FY 2021: 64.6%FY 2022: 38.4%FY 2023: 47.5%FY 2024: 36.5%FY 2025: 35.1%
FY 2017 5y median 38.4% FY 2025
ROIC -108.5%
FY 2017: -49.0%FY 2018: -42.5%FY 2019: -46.6%FY 2020: -77.4%FY 2021: -65.3%FY 2022: -101.4%FY 2023: -149.4%FY 2024: -77.1%FY 2025: -108.5%
FY 2017 5y median -101.4% FY 2025
ROA -77.9%
FY 2017: -31.2%FY 2018: -28.1%FY 2019: -41.2%FY 2020: -63.8%FY 2021: -55.5%FY 2022: -77.2%FY 2023: -117.7%FY 2024: -58.3%FY 2025: -77.9%
FY 2017 5y median -77.2% FY 2025

Growth (YoY)

Revenue 126.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -79.7%FY 2021: 745.1%FY 2022: 11.4%FY 2023: -88.0%FY 2024: 2285.3%FY 2025: 126.3%
FY 2017 FY 2025
Operating Income 4.0%
FY 2017: 0.0%FY 2018: -318.8%FY 2019: -45.0%FY 2020: -78.2%FY 2021: -21.5%FY 2022: 11.2%FY 2023: -18.6%FY 2024: 2.4%FY 2025: 4.0%
FY 2017 FY 2025
EPS (diluted) -31.6%
FY 2017: 0.0%FY 2018: -330.3%FY 2019: -74.6%FY 2020: -65.3%FY 2021: 4.9%FY 2022: 14.1%FY 2023: -17.9%FY 2024: 27.1%FY 2025: -31.6%
FY 2017 FY 2025
Free Cash Flow 14.3%
FY 2017: 0.0%FY 2018: -278.1%FY 2019: -67.1%FY 2020: -57.4%FY 2021: -34.1%FY 2022: 22.0%FY 2023: -24.2%FY 2024: 1.4%FY 2025: 14.3%
FY 2017 FY 2025

Financial Health

Current Ratio 2.6×
FY 2017: 11.4×FY 2018: 13.7×FY 2019: 9.4×FY 2020: 6.7×FY 2021: 6.6×FY 2022: 4.5×FY 2023: 3.3×FY 2024: 4.7×FY 2025: 2.6×
FY 2017 5y median 4.5× FY 2025
Quick Ratio 2.5×
FY 2017: 11.4×FY 2018: 13.7×FY 2019: 9.4×FY 2020: 6.7×FY 2021: 6.6×FY 2022: 4.5×FY 2023: 3.3×FY 2024: 4.7×FY 2025: 2.5×
FY 2017 5y median 4.5× FY 2025
Debt / Equity -1.3×
FY 2017: -2.5×FY 2018: -0.3×FY 2019: 0.2×FY 2020: 8.6×FY 2021: -2.0×FY 2022: -1.4×FY 2023: -1.3×FY 2024: -1.2×FY 2025: -1.3×
FY 2017 5y median -1.3× FY 2025
Net Debt / EBITDA -3.2×
FY 2017: -1.2×FY 2018: 2.1×FY 2019: 1.0×FY 2020: -0.3×FY 2021: -2.5×FY 2022: -3.4×FY 2023: -2.4×FY 2024: -2.4×FY 2025: -3.2×
FY 2017 5y median -2.5× FY 2025
Interest Coverage -10.7×
FY 2017: -3374×FY 2018: -72.1×FY 2019: -30.4×FY 2020: -12.9×FY 2021: -12.3×FY 2022: -6.4×FY 2023: -7.5×FY 2024: -6.0×FY 2025: -10.7×
FY 2017 5y median -7.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: -3.8%FY 2018: 0.0%FY 2019: -0.4%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31